Mitsui Chemicals, Inc.

As of March 31, 2026, Mitsui Chemicals, Inc. carries a market capitalization of 684.11B, placing it among publicly traded companies globally. Its enterprise value stands at 1.33T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Mitsui Chemicals, Inc.'s next confirmed earnings release is scheduled for November 11, 2026.

As of March 31, 2026, Mitsui Chemicals, Inc. has 368.10M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Mitsui Chemicals, Inc. maintains a current ratio of 1.68, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Mitsui Chemicals, Inc.'s stock has gained approximately 10.78% over the past 52 weeks. The 50-day moving average sits at 2,150.38, while the 200-day moving average is 2,112.83.

As of March 31, 2026, Mitsui Chemicals, Inc. holds 217.86B in cash and equivalents against 740.19B in total debt, resulting in a net debt position of 557.08B. Total book value stands at 864.73B, with working capital of 402.06B providing operational flexibility.

Mitsui Chemicals, Inc.'s most recent stock split took place on December 29, 2025 with a 1:2 split ratio.